Anhui Huaheng (China) Today
Anhui Huaheng is trading at 27.18 as of the 5th of February 2025, a 1.02% down since the beginning of the trading day. The stock's open price was 27.46. The performance scores are derived for the period starting the 7th of November 2024 and ending today, the 5th of February 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Valuation Profit Patterns
Check how we calculate scores
Anhui Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Anhui Huaheng's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Anhui Huaheng or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman GM | Henghua Guo | ||||
| Thematic Idea | Biotech (View all Themes) | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Biotech, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Anhui Huaheng's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Anhui Huaheng's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsAnhui Huaheng can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Anhui Huaheng's financial leverage. It provides some insight into what part of Anhui Huaheng's total assets is financed by creditors.
| |||||
Anhui Huaheng Biotechnology (688639) is traded on Shanghai Stock Exchange in China and employs 1,691 people. Anhui Huaheng is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.79 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Anhui Huaheng's market, we take the total number of its shares issued and multiply it by Anhui Huaheng's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Anhui Huaheng Biotec operates under Biotechnology sector and is part of Health Care industry. The entity has 249.72 M outstanding shares.
Anhui Huaheng generates positive cash flow from operations, but has no cash available
Check Anhui Huaheng Probability Of Bankruptcy
Anhui Huaheng Biotec Risk Profiles
Although Anhui Huaheng's alpha and beta are two of the key measurements used to evaluate Anhui Huaheng's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.93 | |||
| Standard Deviation | 2.58 | |||
| Variance | 6.64 | |||
| Risk Adjusted Performance | (0.16) |
Anhui Stock Against Markets
Anhui Huaheng Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Anhui Huaheng stock to make a market-neutral strategy. Peer analysis of Anhui Huaheng could also be used in its relative valuation, which is a method of valuing Anhui Huaheng by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Anhui Huaheng Corporate Directors
| Yi Fan | Deputy Director | Profile | |
| Dongzhu Zhang | Deputy Director | Profile | |
| Xueli Zhang | Chief Director | Profile | |
| Jian Mao | Deputy Director | Profile |
Other Information on Investing in Anhui Stock
Anhui Huaheng financial ratios help investors to determine whether Anhui Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Anhui with respect to the benefits of owning Anhui Huaheng security.